SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-063974
Filing Date
2024-05-23
Accepted
2024-05-23 16:25:28
Documents
2
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 26067
2 EX-24 crsp-ex24.htm EX-24 14345
  Complete submission text file 0000950170-24-063974.txt   41823
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CRISPR THERAPEUTICS 105 WEST FIRST STREET BOSTON MA 02127
Business Address
Bruno Julianne (Reporting) CIK: 0002019645 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37923 | Film No.: 24978672